Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer.

Tempero MA, Klimstra D, Berlin J, Hollingsworth T, Kim P, Merchant N, Moore M, Pleskow D, Wang-Gillam A, Lowy AM.

Clin Cancer Res. 2013 Feb 1;19(3):538-40. doi: 10.1158/1078-0432.CCR-12-2745. Epub 2013 Jan 23. Review.

PMID:
23344262
[PubMed - indexed for MEDLINE]
Free Article
2.

Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.

Fong ZV, Winter JM.

Cancer J. 2012 Nov-Dec;18(6):530-8. doi: 10.1097/PPO.0b013e31827654ea. Review.

PMID:
23187839
[PubMed - indexed for MEDLINE]
3.

Markers of pancreatic cancer: working toward early detection.

Goggins M.

Clin Cancer Res. 2011 Feb 15;17(4):635-7. doi: 10.1158/1078-0432.CCR-10-3074. Epub 2011 Feb 8.

PMID:
21304000
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Molecular markers in pancreatic cancer diagnosis.

Herreros-Villanueva M, Gironella M, Castells A, Bujanda L.

Clin Chim Acta. 2013 Mar 15;418:22-9. doi: 10.1016/j.cca.2012.12.025. Epub 2013 Jan 8. Review.

PMID:
23305796
[PubMed - indexed for MEDLINE]
5.

Caveolin-1: a marker for pancreatic cancer diagnosis.

Tanase CP.

Expert Rev Mol Diagn. 2008 Jul;8(4):395-404. doi: 10.1586/14737159.8.4.395. Review.

PMID:
18598222
[PubMed - indexed for MEDLINE]
6.

Molecular markers of early pancreatic cancer.

Goggins M.

J Clin Oncol. 2005 Jul 10;23(20):4524-31. Review.

PMID:
16002843
[PubMed - indexed for MEDLINE]
Free Article
7.

Screening for early pancreatic ductal adenocarcinoma: an urgent call!

Lee MX, Saif MW.

JOP. 2009 Mar 9;10(2):104-8.

PMID:
19287101
[PubMed - indexed for MEDLINE]
Free Article
8.

[Recent advances in diagnosis of pancreatic cancer].

Yamaguchi K, Ogawa Y, Yokohata K, Konomi H, Nakamura M, Nagata S, Tanaka M.

Gan To Kagaku Ryoho. 2005 May;32(5):612-6. Japanese.

PMID:
15918559
[PubMed - indexed for MEDLINE]
9.

Prognostic markers in pancreatic ductal adenocarcinomas.

Hezel AF, Bardeesy N.

Cancer Biol Ther. 2008 Sep;7(9):1360-1. Epub 2008 Sep 6. No abstract available.

PMID:
18836287
[PubMed - indexed for MEDLINE]
Free Article
10.

Increasing survival rates of patients with pancreatic cancer by earlier identification.

Greenhalf W, Neoptolemos JP.

Nat Clin Pract Oncol. 2006 Jul;3(7):346-7. No abstract available.

PMID:
16826198
[PubMed - indexed for MEDLINE]
11.

Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.

Chung JC, Oh MJ, Choi SH, Bae CD.

ANZ J Surg. 2008 Apr;78(4):245-51. doi: 10.1111/j.1445-2197.2008.04429.x.

PMID:
18366394
[PubMed - indexed for MEDLINE]
12.

Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.

Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR, Brand RE, Hollingsworth MA, Jain M, Batra SK.

Br J Cancer. 2008 May 6;98(9):1540-7. doi: 10.1038/sj.bjc.6604329. Epub 2008 Apr 8.

PMID:
18392050
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Identifying molecular markers for the early detection of pancreatic neoplasia.

Goggins M.

Semin Oncol. 2007 Aug;34(4):303-10. Review. Erratum in: Semin Oncol. 2012 Dec;39(6):716.

PMID:
17674958
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.

Uno K, Azuma T, Nakajima M, Yasuda K, Hayakumo T, Mukai H, Sakai T, Kawai K.

J Gastroenterol Hepatol. 2000 Nov;15(11):1333-8.

PMID:
11129230
[PubMed - indexed for MEDLINE]
15.

Clinical implications of biological markers in Pancreatic Ductal Adenocarcinoma.

Giovinazzo F, Turri G, Zanini S, Butturini G, Scarpa A, Bassi C.

Surg Oncol. 2012 Dec;21(4):e171-82. doi: 10.1016/j.suronc.2012.07.004. Epub 2012 Sep 12. Review.

PMID:
22981281
[PubMed - indexed for MEDLINE]
16.

Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.

Ansari D, Rosendahl A, Elebro J, Andersson R.

Br J Surg. 2011 Aug;98(8):1041-55. doi: 10.1002/bjs.7574. Epub 2011 Jun 6. Review.

PMID:
21644238
[PubMed - indexed for MEDLINE]
17.

Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.

Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, Nakamura Y, Yamao K.

J Gastroenterol. 2010;45(1):52-9. doi: 10.1007/s00535-009-0114-y. Epub 2009 Sep 30.

PMID:
19789838
[PubMed - indexed for MEDLINE]
18.

PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.

Gold DV, Karanjawala Z, Modrak DE, Goldenberg DM, Hruban RH.

Clin Cancer Res. 2007 Dec 15;13(24):7380-7.

PMID:
18094420
[PubMed - indexed for MEDLINE]
Free Article
19.

Early diagnosis of pancreatic cancer; looking for a needle in a haystack?

Bruno MJ.

Gut. 2013 Jul;62(7):955-6. doi: 10.1136/gutjnl-2012-303168. Epub 2012 Sep 18. No abstract available.

PMID:
22990305
[PubMed - indexed for MEDLINE]
20.

Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma.

Szafranska-Schwarzbach AE, Adai AT, Lee LS, Conwell DL, Andruss BF.

Expert Rev Mol Diagn. 2011 Apr;11(3):249-57. doi: 10.1586/erm.11.10.

PMID:
21463235
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk